X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (153486) 153486
Newspaper Article (11905) 11905
Newsletter (2481) 2481
Book Chapter (594) 594
Magazine Article (478) 478
Book / eBook (217) 217
Trade Publication Article (183) 183
Dissertation (80) 80
Web Resource (80) 80
Conference Proceeding (66) 66
Publication (58) 58
Reference (22) 22
Book Review (12) 12
Streaming Video (8) 8
Government Document (5) 5
Journal / eJournal (5) 5
Transcript (3) 3
Report (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
inflammation (129738) 129738
humans (82378) 82378
animals (66121) 66121
male (54529) 54529
female (41402) 41402
mice (32292) 32292
cytokines (25976) 25976
immunology (23294) 23294
middle aged (23073) 23073
adult (19983) 19983
research (19401) 19401
rats (19136) 19136
expression (18234) 18234
inflammation - drug therapy (17937) 17937
disease models, animal (16883) 16883
oxidative stress (16881) 16881
pharmacology & pharmacy (16720) 16720
analysis (16162) 16162
proteins (15970) 15970
aged (15148) 15148
health aspects (14456) 14456
apoptosis (14300) 14300
cell biology (14013) 14013
rodents (14012) 14012
disease (13907) 13907
activation (13653) 13653
medicine (13474) 13474
care and treatment (13164) 13164
gene expression (12694) 12694
risk factors (12094) 12094
cancer (11867) 11867
research article (11843) 11843
biochemistry & molecular biology (10737) 10737
neurosciences (10676) 10676
studies (10388) 10388
multidisciplinary sciences (10312) 10312
mice, inbred c57bl (10056) 10056
patients (9945) 9945
inflammation - metabolism (9541) 9541
medicine, research & experimental (9496) 9496
cells (9439) 9439
treatment outcome (9294) 9294
signal transduction (9286) 9286
macrophages (9240) 9240
pathogenesis (9162) 9162
asthma (9011) 9011
medical research (8891) 8891
physiological aspects (8799) 8799
inflammation - pathology (8724) 8724
nf-kappa-b (8532) 8532
drug therapy (8197) 8197
oncology (8186) 8186
atherosclerosis (8167) 8167
science (8109) 8109
kinases (7980) 7980
tumor necrosis factor-tnf (7943) 7943
rheumatology (7920) 7920
inhibition (7899) 7899
cytokines - metabolism (7839) 7839
diabetes (7712) 7712
arthritis (7678) 7678
therapy (7610) 7610
mortality (7605) 7605
immune system (7586) 7586
review (7505) 7505
biomarkers (7460) 7460
c-reactive protein (7439) 7439
rats, sprague-dawley (7278) 7278
anti-inflammatory agents - pharmacology (7272) 7272
metabolism (7272) 7272
cells, cultured (7262) 7262
surgery (7040) 7040
anti-inflammatory agents - therapeutic use (6972) 6972
pain (6931) 6931
clinical trials (6892) 6892
medicine & public health (6746) 6746
inflammation - immunology (6706) 6706
physiology (6698) 6698
respiratory system (6609) 6609
development and progression (6493) 6493
infections (6356) 6356
pathology (6346) 6346
lymphocytes (6305) 6305
biology (6255) 6255
antioxidants (6216) 6216
rheumatoid arthritis (6207) 6207
immune response (6084) 6084
inflammation mediators - metabolism (6076) 6076
time factors (5874) 5874
enzymes (5841) 5841
signal transduction - drug effects (5807) 5807
mechanisms (5699) 5699
abridged index medicus (5678) 5678
in-vitro (5672) 5672
rats, wistar (5605) 5605
obesity (5512) 5512
dose-response relationship, drug (5509) 5509
animal models (5484) 5484
biomarkers - blood (5365) 5365
diagnosis (5354) 5354
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (99) 99
Online Resources - Online (30) 30
Collection Dvlpm't (Acquisitions) - Vendor file (20) 20
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Scarborough Hospital - General (4) 4
Sunnybrook Health Sciences Centre - Holland Reference (3) 3
Humber River Regional Hospital - Church Stacks (2) 2
Providence Healthcare - Reference (2) 2
St. Michael's Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Holland Stacks (2) 2
Trillium Health Centre - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Baycrest Hospital - Wellness Library (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - May be requested in 6-10 wks (1) 1
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Reserve desk (1) 1
Scarborough Hospital - Birchmount (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Online (1) 1
Women's College Hospital - Reference (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (167425) 167425
Japanese (754) 754
German (696) 696
French (561) 561
Russian (517) 517
Chinese (329) 329
Portuguese (272) 272
Spanish (254) 254
Italian (171) 171
Polish (142) 142
Norwegian (62) 62
Dutch (38) 38
Czech (30) 30
Korean (29) 29
Turkish (28) 28
Hungarian (24) 24
Danish (23) 23
Romanian (21) 21
Swedish (19) 19
Ukrainian (19) 19
Hebrew (15) 15
Bulgarian (10) 10
Finnish (9) 9
Serbian (9) 9
Croatian (4) 4
Slovak (4) 4
Arabic (3) 3
Lithuanian (2) 2
Bosnian (1) 1
Corsican (1) 1
Hindi (1) 1
Persian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Rheumatology (Oxford, England), ISSN 1462-0332, 2019, Volume 58, Issue Supplement_1, pp. i43 - i54
Abstract Janus kinase (JAK)/signal transducers and activators of transcription (STATs) are a group of molecules associated with one of the major pathways... 
FILGOTINIB GLPG0634/GS-6034 | CROHNS-DISEASE | INADEQUATE RESPONSE | PHASE-III | STAT pathway | RHEUMATOLOGY | LONG-TERM EXTENSION | ALOPECIA-AREATA | immune-mediated diseases | CHRONIC PLAQUE PSORIASIS | JAK | JANUS KINASE INHIBITOR | DOUBLE-BLIND | JAK inhibitors | TOFACITINIB-TREATED PATIENTS | Spondylarthropathies - drug therapy | Chilblains - drug therapy | Humans | Dental Enamel Hypoplasia - drug therapy | Metacarpus - abnormalities | Osteoporosis - drug therapy | Immunologic Deficiency Syndromes | Arthritis, Rheumatoid - drug therapy | Lupus Erythematosus, Cutaneous - drug therapy | Arthritis, Psoriatic - drug therapy | Muscular Diseases - drug therapy | Autoimmune Diseases - drug therapy | Inflammatory Bowel Diseases - drug therapy | Psoriasis - drug therapy | Cytokines | Uveitis - drug therapy | Giant Cell Arteritis - drug therapy | Vascular Calcification - drug therapy | Autoimmune Diseases of the Nervous System - drug therapy | Aortic Diseases - drug therapy | Dermatitis, Atopic - drug therapy | Alopecia Areata - drug therapy | Janus Kinase Inhibitors - therapeutic use | Odontodysplasia - drug therapy | Nervous System Malformations - drug therapy | Phosphorylation | Transcription factors | Transcription | Clinical trials | Inflammation | Immunosuppressive agents | Signal transduction | Alopecia | Atopic dermatitis | Rheumatoid arthritis | Janus kinase | Skin diseases | Transduction | Growth factors | Reviews
Journal Article
Inflammation & allergy, ISSN 1871-5281, 2006
Journal
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 20, pp. 1908 - 1919
Journal Article
Nature (London), ISSN 1476-4687, 2016, Volume 539, Issue 7629, pp. 443 - 447
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 12, pp. 1119 - 1131
... subsequently found that beneficial outcomes after statin therapy relate to both a reduction in cholesterol level and inflammation inhibition. 7 – 11 Yet, to date... 
no | C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
Nature (London), ISSN 1476-4687, 2014, Volume 514, Issue 7520, pp. 112 - 116
.... We establish that specific targeting of focal adhesion kinase (FAK; also known as PTK2) in endothelial cells is sufficient to induce tumour-cell sensitization to DNA-damaging therapies and thus inhibit tumour growth in mice... 
CANCER-CELLS | ACTIVATION | METASTASIS | MICROENVIRONMENT | ANGIOGENESIS | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | RESISTANCE | FOCAL ADHESION KINASE | NF-KAPPA-B | EXPRESSION | Doxorubicin - therapeutic use | Apoptosis - drug effects | Apoptosis - radiation effects | Humans | NF-kappa B - metabolism | Cell Nucleus - metabolism | Neoplasms - genetics | DNA Damage - genetics | Neoplasms - radiotherapy | Phosphorylation - drug effects | DNA Damage - drug effects | Endothelial Cells - metabolism | Focal Adhesion Protein-Tyrosine Kinases - metabolism | Focal Adhesion Protein-Tyrosine Kinases - deficiency | Neoplasms - drug therapy | Focal Adhesion Protein-Tyrosine Kinases - genetics | Drug Resistance, Neoplasm - genetics | Animals | Active Transport, Cell Nucleus - drug effects | Cell Proliferation - drug effects | Mice | Cell Nucleus - drug effects | Neoplasms - pathology | Endothelial Cells - enzymology | Cytokines - biosynthesis | Doxorubicin - pharmacology | Cell Proliferation - radiation effects | Drug Resistance, Neoplasm - drug effects | Endothelial Cells - drug effects | Tyrosine | Complications and side effects | Care and treatment | DNA damage | Oncology, Experimental | Genetic research | Genetic aspects | Research | Drug resistance | Phosphotransferases | Health aspects | Cancer | Cell growth | Chemotherapy | Cytokines | Melanoma | Lymphomas | Radiation therapy | Kinases | Cancer therapies | Deoxyribonucleic acid--DNA | Cell adhesion & migration | Tumors
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 01/2007, Volume 13, Issue 3, pp. 333 - 346
.... In that time, many drugs have been developed but none have successfully passed clinical trials... 
Cardiovascular disease | Inflammation | Topical | Acute therapy | Remodeling | SMOKE-INDUCED EMPHYSEMA | cardiovascular disease | remodeling | topical | ABDOMINAL AORTIC-ANEURYSMS | HEART-FAILURE | BLOOD-BRAIN-BARRIER | RESPIRATORY-DISTRESS-SYNDROME | MUSCLE-CELL-MIGRATION | OBSTRUCTIVE PULMONARY-DISEASE | TISSUE-PLASMINOGEN-ACTIVATOR | inflammation | acute therapy | MACROPHAGE ELASTASE MMP-12 | PHARMACOLOGY & PHARMACY | PREVENTS CARDIAC RUPTURE | Hypertrophy, Left Ventricular - enzymology | Humans | Eye Diseases - enzymology | Protease Inhibitors - pharmacology | Atherosclerosis - enzymology | Drug Design | Hypertrophy, Left Ventricular - drug therapy | Protease Inhibitors - therapeutic use | Vascular Diseases - drug therapy | Extracellular Matrix Proteins - metabolism | Myocardial Infarction - enzymology | Atherosclerosis - drug therapy | Heart Rupture, Post-Infarction - enzymology | Neoplasms - enzymology | Skin Diseases - drug therapy | Stroke - drug therapy | Respiratory Distress Syndrome, Adult - drug therapy | Vascular Diseases - enzymology | Arthritis - enzymology | Neoplasms - drug therapy | Pulmonary Disease, Chronic Obstructive - enzymology | Stroke - enzymology | Animals | Myocardial Infarction - drug therapy | Eye Diseases - drug therapy | Arthritis - drug therapy | Matrix Metalloproteinase Inhibitors | Matrix Metalloproteinases - metabolism | Heart Rupture, Post-Infarction - drug therapy | Respiratory Distress Syndrome, Adult - enzymology | Skin Diseases - enzymology | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2013, Volume 339, Issue 6116, pp. 166 - 172
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 01/2017, Volume 76, Issue 1, pp. 17 - 28
Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general... 
Journal Article | FACTOR-ALPHA THERAPY | B-CELL LYMPHOMA | MODIFYING ANTIRHEUMATIC DRUGS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ACUTE MYOCARDIAL-INFARCTION | NECROSIS-FACTOR INHIBITORS | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | ACUTE CORONARY SYNDROME | DOSE GLUCOCORTICOID THERAPY | Cardiovascular Diseases - etiology | Life Style | Risk Assessment | Risk Management - methods | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Spondylitis, Ankylosing - drug therapy | Rheumatology | Spondylitis, Ankylosing - complications | Adrenal Cortex Hormones - therapeutic use | Arthritis, Rheumatoid - complications | Directive Counseling | Arthritis, Psoriatic - complications | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis, Rheumatoid - drug therapy | Arthritis, Psoriatic - drug therapy | Antirheumatic Agents - therapeutic use | Physician's Role | Epidemiologists | Complications and side effects | Care and treatment | Rheumatoid arthritis | Practice | Joint diseases | Cardiovascular diseases | Risk factors | Cardiovascular Disease | Rheumatoid Arthritis | Reumatologi och inflammation | Anti-Inflammatory Agents | Adrenal Cortex Hormones/therapeutic use | Arthritis | Non-Steroidal/therapeutic use | Risk Management/methods | Rheumatology and Autoimmunity | Ankylosing Spondylitis | Spondylitis | Rheumatoid/complications/drug therapy | Ankylosing/complications/drug therapy | Cardiovascular Diseases/etiology/prevention & control | Antirheumatic Agents/therapeutic use | Psoriatic Arthritis | Psoriatic/complications/drug therapy
Journal Article